Vitamin C has always held a crucial position in the global vitamin industry chain. As one of the earliest vitamins to achieve industrialized production and with the widest application range, Vitamin C is widely used in food, pharmaceuticals, health products, feed, cosmetics, and functional nutritional products. With the continuous growth of global health consumption demand and the increasing demand for high-quality raw materials from the food and pharmaceutical industries, the Vitamin C industry is gradually developing towards large-scale, intensive, and full-chain development. Against this backdrop, Luwei Pharmaceutical Group Co., Ltd., with its complete industrial chain layout, advanced production technology, and mature international market system, has grown into one of the leading Vitamin C producers in China.
Founded in 1995 and headquartered in Zibo City, Shandong Province, Luwei Pharmaceutical is a large-scale comprehensive enterprise group integrating corn deep processing, bio-fermentation, raw material drug production, international trade, and circular economy. After nearly 30 years of continuous development, the company has gradually built a complete industrial system centered on the vitamin C industry, forming a full-process operation model covering raw material supply, manufacturing, quality control, product research and development, and global sales. With stable product quality and international operating capabilities, Luwei Pharmaceutical's products have been exported to more than 160 countries and regions worldwide, establishing a broad customer base in markets such as Europe, America, Japan, Southeast Asia, the Middle East, and Latin America.
Unlike many companies that solely engage in vitamin C production, one of Luwei Pharmaceutical's biggest competitive advantages lies in its complete industrial chain layout. The industrial production of vitamin C mainly adopts the classic "two-step fermentation method," with glucose being the core raw material throughout the entire production process. To enhance the stability of raw material supply and reduce production costs, Luwei Pharmaceutical has extended upstream in the industrial chain, establishing a complete corn deep-processing system. Starting from corn procurement, through starch processing, glucose production, sorbitol manufacturing, and then to 2-keto-L-gulonic acid (2-KLG) fermentation and final vitamin C synthesis, the company has achieved full industrial chain coverage from agricultural products to high-value-added vitamin products.
This industrial model not only effectively reduces the impact of external raw material price fluctuations on production costs but also improves the controllability of product quality and the stability of the supply chain. In the context of increasingly fierce international market competition, companies with complete industrial chains tend to maintain stronger risk resistance and higher profitability, which is one of the key reasons why Luwei Pharmaceutical has been able to maintain its competitive advantage for a long time.
After years of expansion and technological upgrades, Luwei Pharmaceutical has achieved a large-scale vitamin C production capacity. The company's vitamin C products cover multiple series, including food-grade, pharmaceutical-grade, and feed-grade, and it can provide various specifications and customized products according to different market demands. As a significant player in China's vitamin C industry, Luwei Pharmaceutical, along with companies such as CSPC Pharmaceutical Group, Northeast Pharmaceutical, and Tianli Pharmaceutical, constitutes a major supply force in the global vitamin C industry and occupies an important position in the international market.
In terms of product structure, Luwei Pharmaceutical not only produces traditional vitamin C raw powder (Ascorbic Acid) but has also established a relatively complete vitamin C derivative product system. Vitamin C raw powder, as one of the company's core products, has excellent antioxidant properties and physiological activity and can be widely used in food fortification, beverage additives, pharmaceutical preparations, and animal nutrition. In the food industry, vitamin C is commonly used as an antioxidant and flour improver, effectively extending shelf life and improving product quality. In the pharmaceutical industry, it is widely used in the production of vitamin supplements, injections, and various compound preparations. In the feed industry, vitamin C enhances animal immunity, improves stress resistance, and boosts production performance.
To meet the higher processing performance requirements of the health food and pharmaceutical industries, Luwei Pharmaceutical has also developed a series of products including ultrafine vitamin C powder (Ascorbic Acid Fine Powder) and direct-compression vitamin C granules (Ascorbic Acid Granulation). The ultrafine powder products offer faster dissolution and superior dispersibility, making them suitable for the production of solid beverages, functional foods, and high-end nutritional supplements. Granular vitamin C, on the other hand, possesses good flowability and tableting properties, offering significant advantages in the manufacture of tablets, effervescent tablets, and health supplements.
In addition to traditional vitamin C products, Luwei Pharmaceutical is also actively expanding into the high-value-added vitamin C derivative market. Sodium Ascorbate, the sodium salt of ascorbic acid, has lower acidity and better stability than regular vitamin C, making it widely used in meat color preservation, pharmaceuticals, and specialty nutritional products. Calcium Ascorbate combines the functions of supplementing both vitamin C and calcium while reducing stomach irritation, thus showing broad application prospects in children's nutritional products, elderly health products, and functional foods.
In the high-end product sector, Luwei Pharmaceutical has also developed stable vitamin C derivatives such as L-Ascorbate-2-Phosphate. These products exhibit excellent thermal stability and antioxidant properties, finding widespread use in aquaculture, animal feed, and the cosmetics industry. Particularly in aquaculture, stable vitamin C effectively improves the disease resistance and growth performance of fish and shrimp, leading to continued market demand growth. With the development of the global functional nutrition and animal health industries, these high-value-added derivative products are gradually becoming a new growth point for the vitamin C industry.
As a vitamin manufacturer targeting the international market, Luwei Pharmaceutical highly values the construction of its quality management system. The company has established a comprehensive quality management system covering raw material procurement, manufacturing, quality testing, warehousing and logistics, and international trade. It has successively passed numerous international certifications, including GMP, ISO9001, ISO22000, ISO14001, ISO45001, FSSC22000, BRC, FAMI-QS, and HALAL. These certifications not only demonstrate the company's comprehensive strength in quality management but also provide crucial guarantees for its products entering high-standard markets such as Europe, America, and Japan.
Regarding technological innovation, Luwei Pharmaceutical consistently adheres to a research-driven development strategy. The company has established a corporate technology center, engineering laboratories, and multiple innovation platforms, and continuously increases its R&D investment in bio-fermentation technology, vitamin derivative development, energy-saving and consumption-reducing processes, and comprehensive resource utilization. Through continuous optimization of fermentation processes and production flows, the company has achieved significant results in improving product yield, reducing energy consumption, and minimizing environmental emissions, laying a solid foundation for the company's long-term sustainable development.
In recent years, as global manufacturing has shifted towards green and low-carbon practices, Luwei Pharmaceutical has further promoted the construction of a circular economy industrial park and actively built a green manufacturing system. By integrating multiple links such as energy supply, corn deep processing, vitamin production, and comprehensive utilization of by-products, the company achieves resource recycling and energy cascade utilization, forming a distinctive circular economy development model. This model not only improves resource utilization efficiency but also significantly reduces carbon emissions and environmental burden during production, giving the company a stronger competitive edge in green manufacturing and sustainable development.
Looking at the global vitamin C industry development trend, future market competition will no longer be limited to simple production capacity, but will be more reflected in the ability to integrate the industrial chain, optimize product structure, innovate technologies, and achieve green manufacturing standards. With its complete corn deep processing industrial chain, mature fermentation technology system, rich vitamin C product portfolio, and global sales network, Luwei Pharmaceutical already possesses the foundation for higher-level development.
In the future, the company will continue to expand the production scale of vitamin C and its derivatives, focusing on the development of high value-added products such as sodium vitamin C, calcium vitamin C, and L-Ascorbate-2-Phosphate, while continuously improving its green manufacturing and circular economy levels, and further strengthening its international market presence. With the continued growth of the global nutrition and health industry and the increasing demand for high-quality vitamin raw materials, Luwei Pharmaceutical is expected to further consolidate its important position in the global vitamin C industry chain and gradually move towards becoming a world-leading comprehensive vitamin C supplier.
